The multi-decade search for a pill that boosts sexual desire in women has hit another roadblock, raising questions about the future of efforts to develop a female equivalent to Viagra.
The Food and Drug Administration has approved the first generic versions of the blockbuster antidepressant Cymbalta, offering lower-cost access to one of the most widely prescribed treatments for depression, anxiety and other disorders.
In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy cancer.
Federal health officials, after encouraging alternate sign-up methods amid the fumbled rollout of their online insurance website, began quietly urging counselors around the country this week to stop using paper applications to enroll people in health insurance because of concerns those applications would not be processed in time.
The California health exchange says it's been giving the names of tens of thousands of consumers to insurance agents without their permission or knowledge in an effort to hit deadlines for coverage.
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
The Obama administration is delaying yet another aspect of the health care law, putting off until next November the launch of an online portal to the health insurance marketplace for small businesses.
Delays in appointments, payments expected after conversion
Local health care organizations want the public to be aware the federal government is requiring the health care industry to transition to an updated medical coding system by Oct. 1, 2014. ICD-10 will require physicians to be much more specific in their documentation.
A national anti-abortion group is pressing Rhode Island's health insurance marketplace to offer plans that don't cover abortion services, saying that failing to do so is "blatantly violating" the rights of those who object to the procedure.
Federal health officials say that defects in some Medtronic devices used in heart procedures are severe enough that they could cause serious injury or death. The warning covers about 15,000 recalled guidewires, which are inserted through an artery and used to guide other devices into place, such as stents to hold open blocked arteries.
Bowing to pressure, President Barack Obama on Thursday announced changes to his health care law to give insurance companies the option to keep offering consumers plans that would otherwise be canceled.
A University of Missouri researcher says orthopedic surgeons are not often identifying domestic violence as a possible cause of the injuries they treat.
Two Wisconsin sisters have filed a federal claim, saying they believe a cervical cancer vaccine caused their ovaries to stop producing eggs.
Heart-clogging trans fats were once a staple of the American diet, plentiful in baked goods, microwave popcorn and fried foods. Now, mindful of the health risks, the Food and Drug Administration is getting rid of what's left of them for good.
Dean Griffin liked the health insurance he purchased for himself and his wife three years ago and thought he'd be able to keep the plan even after the federal Affordable Care Act took effect. But the 64-year-old recently received a letter notifying him the plan was being canceled because it didn't cover certain benefits required under the law.
Experts: ACOs could improve health care quality, efficiencies
Accountable Care Organizations (ACO) that have been successful with Medicare could be viable options for Missouri’s Medicaid system, state health experts say.
As states open insurance marketplaces amid uncertainty about whether they're a solution for health care, Vermont is eyeing a bigger goal, one that more fully embraces a government-funded model.
The Food and Drug Administration has approved a stronger, single-ingredient version hydrocodone, the widely-abused prescription painkiller.
The Food and Drug Administration is recommending new restrictions on prescription medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.
An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government advisers who say the medication should be approved to treat patients infected with the liver-destroying virus.